Skip to content
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Cardiology

Which Medications Trigger Prinzmetal Angina Spasms?

At a Glance

Triptans and ergot medicines, 5-FU and capecitabine chemotherapy, decongestants, some beta-blockers, cocaine, and nicotine can trigger Prinzmetal angina spasms. Review every medicine with a clinician, and seek emergency care for severe or unusual chest pain.

Certain medications can trigger Prinzmetal angina (coronary vasospasm) because their primary function or side effect is vasoconstriction—the narrowing of blood vessels. If you already have a tendency for your heart’s arteries to spasm, taking these drugs can provoke a severe and potentially dangerous episode. Important medication-related triggers include specific migraine medications (called triptans and ergot derivatives) and certain chemotherapy drugs used to treat cancer.

Always review every prescription, over-the-counter product, nasal spray, and supplement with your clinician or pharmacist before starting or stopping any treatment.

Emergency Warning

If you experience new, severe, persistent, or unusual chest pain, shortness of breath, fainting, marked sweating, or palpitations, call emergency services immediately. Do not drive yourself to the hospital. Follow your doctor’s instructions for using your prescribed nitroglycerin. A severe coronary spasm can lead to a true heart attack or dangerous heart rhythm [1][2]. Even if you suspect a medication caused the symptoms, you need urgent emergency evaluation [3].

Migraine Medications to Avoid

If you have Prinzmetal angina, you should not take a class of migraine medications known as triptans or ergot derivatives unless a specialist has thoroughly reviewed your case and explicitly approved their use [4][5]. Product labeling and clinical guidance generally consider vasospastic coronary disease a reason not to use these drugs (a contraindication).

Triptans work by stimulating specific receptors (called 5-HT1B receptors) that cause blood vessels in the brain to constrict, helping to stop a migraine attack [6]. However, these same receptors are in your heart’s coronary arteries. When activated, they can cause your heart’s arteries to narrow, triggering a spasm [6].

Specific triptans include:

  • Sumatriptan [7][8]
  • Rizatriptan [9]
  • Zolmitriptan [8]
  • Eletriptan [10]
  • Naratriptan, Frovatriptan, and Almotriptan [9]

There have been reports of severe heart events, including heart attacks and dangerous heart rhythms, linked to sumatriptan and other triptans [7][11]. Similarly, ergot derivatives (such as ergotamine and dihydroergotamine) constrict blood vessels and pose similar cardiovascular risks [4][5]. Do not make unsupervised changes if you are currently taking these; contact your prescriber.

Non-vasoconstricting options to discuss:
Drugs like lasmiditan and a class known as gepants (such as ubrogepant and rimegepant) are not direct vasoconstrictors [12][13]. While they don’t cause triptan-like blood vessel narrowing, their cardiovascular safety data in patients with vasospastic disease is limited [12][13]. A neurologist or cardiologist must review your individual health history and potential drug interactions before prescribing them.

Cancer Medications That Can Trigger Spasms

Certain chemotherapy drugs, specifically a class called fluoropyrimidines, are well-established triggers for coronary vasospasm and broader heart toxicity (which can include heart attacks and arrhythmias) [14][15]. These include:

  • 5-fluorouracil (5-FU): An intravenous chemotherapy [14][15].
  • Capecitabine: An oral pill that works similarly [14][15].

Symptoms can happen within hours or days of starting the medication [3]. If you experience chest pain while taking these drugs, seek emergency care immediately and notify your oncology team. Do not simply stop the medication on your own without a doctor’s plan, but active infusions are generally stopped by the medical team while you are evaluated for acute coronary syndrome [3][16]. Any plan to restart treatment (a rechallenge) requires careful coordination between oncology and cardiology, often using medications like calcium-channel blockers or nitrates to relax blood vessels [16][17].

Rare case reports also suggest that nilotinib, a drug used for leukemia, may cause vasospasms, though it is more established as causing other arterial issues [18].

Other Important Medications to Discuss

  • Beta-blockers: These are common heart medications, but some (particularly non-selective beta-blockers) can worsen coronary vasospasm in certain patients [19][20]. However, never stop a beta-blocker abruptly, as this can be dangerous. Discuss your medications with your cardiologist [20].
  • Decongestants and Cold Medicines: Over-the-counter cold, allergy, and sinus medications often contain pseudoephedrine or phenylephrine. These are sympathomimetics that narrow blood vessels and can trigger spasms [21]. Always check the active ingredients of combination products.
  • Epinephrine (Adrenaline) in Emergencies: Epinephrine can increase vasoconstriction [22]. However, you should NEVER delay or refuse life-saving epinephrine in an emergency, such as for a severe allergic reaction (anaphylaxis). Inform emergency personnel about your Prinzmetal angina, but accept the treatment [22].
  • Recreational Drugs and Nicotine: Cocaine is a powerful vasoconstrictor and a well-known trigger for severe coronary spasms [23]. Cigarette smoking is strongly associated with triggering vasospastic angina [24]. If you are using nicotine replacement products to quit smoking, discuss this with your care team.

Quick Reference Guide

Medication / Substance Examples Level of Concern Patient Action
Triptans & Ergots Sumatriptan, rizatriptan, ergotamine High (Contraindicated) Do not use unless a specialist explicitly directs you to. [4]
Fluoropyrimidines 5-fluorouracil (5-FU), capecitabine High Discuss cardio-oncology monitoring. Seek emergency care if chest pain occurs. [3]
OTC Decongestants Pseudoephedrine, phenylephrine Moderate Check active ingredients. Ask a pharmacist before use. [21]
Beta-blockers Propranolol, metoprolol Moderate Discuss with your cardiologist. Never stop abruptly. [20]
Emergency Epinephrine EpiPen, adrenaline Emergency Use Never delay in a life-threatening emergency. Inform EMTs of your condition. [22]

Common questions in this guide

Which migraine medications can trigger Prinzmetal angina?
Triptans, such as sumatriptan and rizatriptan, and ergot derivatives, such as ergotamine and dihydroergotamine, constrict blood vessels and may provoke coronary spasms. They are generally not used in people with vasospastic coronary disease unless a specialist explicitly approves them. Do not stop a current medicine without contacting the prescriber.
Can 5-FU or capecitabine cause coronary spasms?
Yes. These chemotherapy drugs can cause coronary vasospasm and other heart problems, sometimes within hours or days of treatment. Chest pain while taking either drug is an emergency; seek immediate care and notify your oncology team rather than changing treatment on your own.
Which over-the-counter cold medicines should I avoid?
Products containing pseudoephedrine or phenylephrine can narrow blood vessels and may trigger spasms. Check active ingredients in combination cold, allergy, sinus, and nasal products, and ask a pharmacist about safer alternatives.
Can beta-blockers worsen Prinzmetal angina?
Some beta-blockers, especially non-selective types, may worsen coronary vasospasm in some people. Never stop a beta-blocker suddenly; ask your cardiologist whether your current medicine is appropriate.
Are lasmiditan or gepants safe if I have Prinzmetal angina?
Lasmiditan and gepants such as ubrogepant and rimegepant do not directly constrict blood vessels like triptans. However, safety information in people with vasospastic disease is limited, so a neurologist or cardiologist should review your history and possible interactions before prescribing them.
Should I avoid epinephrine because I have Prinzmetal angina?
No. Do not delay or refuse epinephrine for life-threatening anaphylaxis because it can be lifesaving. Tell emergency personnel that you have Prinzmetal angina so they can monitor and treat you appropriately.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Prinzmetal angina.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my Prinzmetal angina, what non-vasoconstricting options exist for managing my severe migraines?
  2. 2.If I need chemotherapy with 5-fluorouracil or capecitabine, how will my cardiology and oncology teams coordinate to monitor my heart and plan alternatives?
  3. 3.Are there specific over-the-counter cold, allergy, or sinus ingredients I should completely avoid, and what are safe alternatives?
  4. 4.Should I carry a medical-alert card listing my diagnosis, prescribed rescue medicines, and contraindicated medications?
  5. 5.Are any of my current daily medications, such as beta-blockers, potentially worsening my spasms?

References

References (24)
  1. 1

    Vasospastic angina: a review on diagnostic approach and management.

    Jenkins K, Pompei G, Ganzorig N, et al.

    Therapeutic advances in cardiovascular disease 2024; (18()):17539447241230400 doi:10.1177/17539447241230400.

    PMID: 38343041
  2. 2

    Spontaneous Multivessel Coronary Spasm During Diagnostic Coronary Angiography.

    Damera RR, Ijlal Khan M, Oliynyk V, Javaid A

    Texas Heart Institute journal 2022; (49(2)) doi:10.14503/THIJ-20-7357.

    PMID: 35377456
  3. 3

    Vasospastic Angina Following Capecitabine Initiation: A Rare But Serious Cardiotoxic Effect.

    Ponce Simal S, Martínez Fleta M, Prados Arnedo M, et al.

    The Journal of emergency medicine 2026; (82()):94-98 doi:10.1016/j.jemermed.2025.12.027.

    PMID: 41687429
  4. 4

    The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans.

    Whealy M, Becker WJ

    Handbook of clinical neurology 2024; (199()):17-42 doi:10.1016/B978-0-12-823357-3.00008-2.

    PMID: 38307644
  5. 5

    Migraine.

    Ferrari MD, Goadsby PJ, Burstein R, et al.

    Nature reviews. Disease primers 2022; (8(1)):2 doi:10.1038/s41572-021-00328-4.

    PMID: 35027572
  6. 6

    Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

    Rubio-Beltrán E, Labastida-Ramírez A, Villalón CM, MaassenVanDenBrink A

    Pharmacology & therapeutics 2018; (186()):88-97 doi:10.1016/j.pharmthera.2018.01.005.

    PMID: 29352859
  7. 7

    Fatal coronary vasospasm following oral triptan intake.

    Djellal IY, Mansour S, Berdaoui B, et al.

    Journal of cardiology cases 2025; (31(6)):170-173 doi:10.1016/j.jccase.2025.02.007.

    PMID: 40519697
  8. 8

    Cardiovascular adverse events associated with triptans for treatment of migraine: a pharmacovigilance study of the FDA adverse event reporting system (FAERS).

    Sharma P, Varghese Gupta S, Bhatt P, et al.

    Canadian journal of physiology and pharmacology 2024; (102(12)):720-728 doi:10.1139/cjpp-2024-0117.

    PMID: 39435747
  9. 9

    Targeting the 5-HT1B/1D and 5-HT1F receptors for acute migraine treatment.

    Huang PC, Yang FC, Chang CM, Yang CP

    Progress in brain research 2020; (255()):99-121 doi:10.1016/bs.pbr.2020.05.010.

    PMID: 33008517
  10. 10

    Eletriptan-Associated Coronary Vasospasm in a Heart Transplant Recipient.

    Yong Y, Teng LE, Velusamy R, et al.

    JACC. Case reports 2026; 109808 doi:10.1016/j.jaccas.2026.109808.

    PMID: 42610998
  11. 11

    A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy.

    Xu N, Lu X

    Journal of pain research 2025; (18()):5331-5345 doi:10.2147/JPR.S551333.

    PMID: 41103977
  12. 12

    Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan.

    Rubio-Beltrán E, Labastida-Ramírez A, Haanes KA, et al.

    British journal of pharmacology 2019; (176(24)):4681-4695 doi:10.1111/bph.14832.

    PMID: 31418454
  13. 13

    Integrating gepants into clinical practice for the acute treatment of migraine.

    Lipton RB, Dodick DW, Davis L, et al.

    Headache 2026; (66(4)):976-989 doi:10.1111/head.70047.

    PMID: 41709494
  14. 14

    The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary Vasospasm.

    Zafar A, Drobni ZD, Mosarla R, et al.

    JACC. CardioOncology 2021; (3(1)):101-109 doi:10.1016/j.jaccao.2020.12.005.

    PMID: 33817666
  15. 15

    Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.

    Dyhl-Polk A, Vaage-Nilsen M, Schou M, et al.

    Acta oncologica (Stockholm, Sweden) 2020; (59(4)):475-483 doi:10.1080/0284186X.2019.1711164.

    PMID: 31931649
  16. 16

    5-Fluorouracil-Induced Microvascular Vasospasm Diagnosed by Coronary Functional Testing.

    Rana R, Wallace RL, Waksman R, et al.

    JACC. Case reports 2025; (30(27)):105137 doi:10.1016/j.jaccas.2025.105137.

    PMID: 40940119
  17. 17

    The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.

    Fabin N, Bergami M, Cenko E, et al.

    Journal of clinical medicine 2022; (11(5)) doi:10.3390/jcm11051244.

    PMID: 35268333
  18. 18

    Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib.

    Maruta S, Usami K, Tajiri K, et al.

    Cardio-oncology (London, England) 2021; (7(1)):31 doi:10.1186/s40959-021-00119-6.

    PMID: 34452646
  19. 19

    Pharmacotherapy of Vasospastic Angina.

    Harris JR, Hale GM, Dasari TW, Schwier NC

    Journal of cardiovascular pharmacology and therapeutics 2016; (21(5)):439-51 doi:10.1177/1074248416640161.

    PMID: 27081186
  20. 20

    Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina: A prospective, randomized, double-blind pilot study.

    Kook H, Hong SJ, Yang KS, et al.

    PloS one 2020; (15(9)):e0239039 doi:10.1371/journal.pone.0239039.

    PMID: 32915892
  21. 21

    Acute Myocardial Infarction from Coronary Vasospasm Precipitated by Pseudoephedrine and Metoprolol Use.

    Meoli EM, Goldsweig AM, Malm BJ

    The Canadian journal of cardiology 2017; (33(5)):688.e1-688.e3 doi:10.1016/j.cjca.2017.01.005.

    PMID: 28347584
  22. 22

    Tacrolimus-Induced Diffuse Coronary Artery Spasm.

    Samer A, Almehmadi F, Krimly A, Alrajhi A

    Cureus 2022; (14(6)):e25748 doi:10.7759/cureus.25748.

    PMID: 35812568
  23. 23

    Cocaine-induced pseudo-Wellens' syndrome: a Wellens' phenocopy.

    Lin AN, Lin S, Gokhroo R, Misra D

    BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-222835.

    PMID: 29246935
  24. 24

    The Smoking Paradox: A Twist in the Tale of Vasospastic Angina.

    Tran MV, Marceau E, Lee PY, et al.

    Journal of vascular medicine & surgery 2021; (9(7)).

    PMID: 36276915

This page explains medication and substance triggers for Prinzmetal angina for informational purposes only and does not constitute medical advice. Have a cardiologist or pharmacist review your medicines before you start, stop, or change them.